These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 27303812)
1. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7. Liu J; Zhou Y; Shi Z; Hu Y; Meng T; Zhang X; Zhang S; Zhang J DNA Cell Biol; 2016 Sep; 35(9):521-9. PubMed ID: 27303812 [TBL] [Abstract][Full Text] [Related]
2. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway. Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways. Han M; Wang F; Gu Y; Pei X; Guo G; Yu C; Li L; Zhu M; Xiong Y; Wang Y Oncol Rep; 2016 Jan; 35(1):73-80. PubMed ID: 26531758 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004 [TBL] [Abstract][Full Text] [Related]
5. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway. Fu Y; Tang Y; Wang J; Guo Z Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735 [TBL] [Abstract][Full Text] [Related]
7. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397 [TBL] [Abstract][Full Text] [Related]
8. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
9. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition. Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Li Q; Zou C; Zou C; Han Z; Xiao H; Wei H; Wang W; Zhang L; Zhang X; Tang Q; Zhang C; Tao J; Wang X; Gao X Cancer Lett; 2013 Jul; 335(1):168-74. PubMed ID: 23435373 [TBL] [Abstract][Full Text] [Related]
11. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770 [TBL] [Abstract][Full Text] [Related]
12. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer. Tian X; Zhang Z IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596 [TBL] [Abstract][Full Text] [Related]
13. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563 [TBL] [Abstract][Full Text] [Related]
14. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283 [TBL] [Abstract][Full Text] [Related]
15. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor. Gao B; Hao S; Tian W; Jiang Y; Zhang S; Guo L; Zhao J; Zhang G; Yan J; Luo D J Gene Med; 2017 Dec; 19(12):. PubMed ID: 27813254 [TBL] [Abstract][Full Text] [Related]
17. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2. Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells. Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931 [TBL] [Abstract][Full Text] [Related]
19. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681 [TBL] [Abstract][Full Text] [Related]
20. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7. Zhu M; Zhang N; He S; Lu X Cell Cycle; 2020 May; 19(10):1200-1221. PubMed ID: 32267797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]